The small molecule KHS101 induces bioenergetic dysfunction in glioblastoma cells through inhibition of mitochondrial HSPD1
Euan S. Polson(University of Leeds), Heiko Wurdak(University of Leeds), Verena Kuchler(University of Salzburg), Bárbara da Silva(University of Leeds), Robin S. Bon(University of Leeds), Christopher Abbosh(Cancer Research UK), Hester A. Beard(University of Leeds), Hao Shao(Institute for Neurodegenerative Disorders), Jennifer M. Williams(South African Medical Research Council), Simon J. Allison(University of Huddersfield), Edith Ross(Merck KGaA, Darmstadt (Germany)), Shoutian Zhu(Scripps Research Institute), Anjana Patel(University of Leeds), Ryan Mathew(Leeds Teaching Hospitals NHS Trust), Jason E. Gestwicki(University of California, San Francisco), Paul Chumas(Leeds General Infirmary), Mihaela Lorger(University of Leeds), Eulashini Chuntharpursat‐Bon(University of Leeds), Alastair Droop(Wellcome Sanger Institute), Florian Markowetz(Cancer Research UK), Adam J. Davies(University of Leeds), Susan Short(Washburn University), Hollie B. S. Griffiths(University of Huddersfield)
Cited by 2
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain Metastasis
|American Journal Of Pathology|2010|353
Structure–activity Relationships of Amyloid Beta‐aggregation Inhibitors Based on Curcumin: Influence of Linker Length and Flexibility
|Chemical Biology & Drug Design|2007|326